Abstract:A 54-year-old white woman was referred with a 3-month history of persistent, painful mouth ulcers occurring on the lip and tongue (Fig. 1), rendering talking and eating painful. There had been no improvement with topical steroid preparations, and the only treatment that cleared the ulcers was a 5-day course of oral prednisolone 30 mg ⁄ day. However, repeated courses were required as the ulcers recurred within a few days of each course. A biopsy of the oral ulcers revealed features consistent with either an allergic response or erythema multiforme (EM). Negative immunofluorescence excluded immunobullous disease. Patch testing did not reveal any relevant allergens. Four months following the initial presentation to our department, the patient developed classic target lesions over her chest and arms. Histologically, an epidermal pattern of EM was confirmed. At this stage, azathioprine was added as a steroid-sparing agent in view of her cushingoid appearance. However, it was not until a routine appointment 9 months after her initial presentation to our department that the aetiology of our patient’s EM became clear. At this visit, examination revealed grouped vesicles over her buttock typical of herpes simplex virus (HSV) infection. These lesions had been a recurring problem, noted following a sexual assault 9 years previously, and had been confirmed on culture. Because of this traumatic association, the information had not previously come to light. Oral acyclovir was commenced at the dose of 200 mg, five times daily for 5 days. This was followed by a long-term prophylactic dose of 400 mg twice daily. One month later her oral ulcers had completely resolved and prednisolone and azathioprine were gradually curtailed. She has remained free from oral ulceration on prophylactic acyclovir alone for over a year, confirming HSV infection as the aetiological agent. Erythema multiforme (EM) is an acute mucocutaneous hypersensitivity reaction classically recognized by its target lesions. EM is usually self-limiting but occasionally recurrent and chronic eruptions occur. It has an incidence of 1 per million and occurs most commonly between the ages of 20–40 years, although children over 3 years of age and teenagers represent 20% of cases. EM is brought on by a range of precipitating factors but viral or bacterial infection and medicaments are the usual culprits. The most common cause of recurrent EM is HSV infection, with 70% of patients with EM attributable to HSV having oral mucosal involvement, as do 40–60% of patients with EM of other aetiology. However, diagnosis can be difficult when EM is limited to the mouth. The commonest causes of chronic oral ulceration are erosive lichen planus and immunobullous diseases, the initial clinical differential diagnoses for our patient. Oral EM (OEM) is well recognized, but to occur alone without classic skin lesions is rare. Cutaneous involvement typical of EM may only be seen in 25% of patients with OEM. Mucosal lesions in EM usually begin as erythematous areas that blister and break down to irregular, painful erosions with extensive surrounding erythema. The lips are often involved with a serosanguineous exudate leading to crusting of the swollen lips. We highlight that a differential diagnosis of OEM should always be considered in a patient presenting with recurrent oral ulceration, especially if the lips are involved and the patient is young. Establishing the correct diagnosis requires a careful history, examination of the appearance of the ulceration, characteristic PD

One-pot Synthesis of Multipod Au-Cu Nanocrystals with Tunable Branching for Efficient Photothermal Treatment Against Multidrug-Resistant Bacteria

Metal-Organic Framework Modified MoS2 Nanozyme for Synergetic Combating Drug-Resistant Bacterial Infections Via Photothermal Effect and Photodynamic Modulated Peroxidase-Mimic Activity.

Ag-Hybridized Plasmonic Au-triangular Nanoplates: Highly Sensitive Photoacoustic/raman Evaluation and Improved Antibacterial/photothermal Combination Therapy

Tlyp-1-conjugated Au-nanorod@SiO(2) Core-Shell Nanoparticles for Tumor-Targeted Drug Delivery and Photothermal Therapy.

Multifunctional Plasmon-Tunable Au Nanostars and Their Applications in Highly Efficient Photothermal Inactivation and Ultra-Sensitive SERS Detection

Integration of Antimicrobial Peptides and Gold Nanorods for Bimodal Antibacterial Applications.

Infection Microenvironment-Responsive Multifunctional Peptide Coated Gold Nanorods For Bimodal Antibacterial Applications

Facile One-Pot Synthesis of Meteor Hammer-like Au-MnO x Nanozymes with Spiky Surface for NIR-II Light-Enhanced Bacterial Elimination

Facile One-Pot Synthesis of Meteor Hammer-like Au-MnOx Nanozymes with Spiky Surface for NIR-II Light-Enhanced Bacterial Elimination

Au–Cu Bimetallic Nanostructures for Photothermal Antibacterial and Wound Healing Promotion

Near-infrared Light-Responsive Photothermal Α-Fe2o3@au/pda Core/shell Nanostructure with On-off Controllable Anti-Bacterial Effects.

Anisotropic α-Fe 2 O 3 /AgAu/Polydopamine Nanostructures for Photothermally Enhanced Antibacterial Applications

Synergistic photothermal effect and nanoenzyme for efficient antibacterial activity

Erythema multiforme presenting as chronic oral ulceration due to unrecognised herpes simplex virus infection

Plasmonic AuPt@CuS Heterostructure with Enhanced Synergistic Efficacy for Radiophotothermal Therapy

Anisotropic Α-Fe2o3/agau/polydopamine Nanostructures for Photothermally Enhanced Antibacterial Applications

Dipolar-hollowed α-Fe 2 O 3 @Au/Polydopamine nanospindle for photothermal-photodynamic coupling antibacterial and drug-delivery

Enhancing the Plasmon Resonance Absorption of Multibranched Gold Nanoparticles in the Near-Infrared Region for Photothermal Cancer Therapy: Theoretical Predictions and Experimental Verification

Au@Pt Nanostructures: a Novel Photothermal Conversion Agent for Cancer Therapy.

Bi2S3 coated Au nanorods for enhanced photodynamic and photothermal antibacterial activities under NIR light

Cu 2− x S x Capped AuCu Nanostars for Efficient Plasmonic Photothermal Tumor Treatment in the Second Near‐Infrared Window